114 related articles for article (PubMed ID: 8320837)
41. Insurmountable AT(1) receptor antagonism: the need for different antagonist binding states of the receptor.
Vauquelin G; Fierens F; Verheijen I; Vanderheyden P
Trends Pharmacol Sci; 2001 Jul; 22(7):343-4. PubMed ID: 11460825
[No Abstract] [Full Text] [Related]
42. Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.
Shah DI; Sharma M; Bansal Y; Bansal G; Singh M
Eur J Med Chem; 2008 Sep; 43(9):1808-12. PubMed ID: 18158200
[TBL] [Abstract][Full Text] [Related]
43. Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies.
Ridgway H; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Hoffmann W; Węgrzyn K; Vassilaki N; Mpekoulis G; Zouridakis M; Giastas P; Vidali VP; Kelaidonis K; Matsoukas MT; Dimitriou M; Mavromoustakos T; Tsiodras S; Gorgoulis VG; Karakasiliotis I; Chasapis CT; Matsoukas JM
Expert Opin Ther Targets; 2024 May; 28(5):437-459. PubMed ID: 38828744
[TBL] [Abstract][Full Text] [Related]
44. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of potential prodrugs of benzimidazole-7-carboxylic acids.
Kubo K; Kohara Y; Yoshimura Y; Inada Y; Shibouta Y; Furukawa Y; Kato T; Nishikawa K; Naka T
J Med Chem; 1993 Aug; 36(16):2343-9. PubMed ID: 8360879
[TBL] [Abstract][Full Text] [Related]
45. Pharmacological characterization of Abbott-81282, a novel, non-peptide angiotensin-II antagonist selective for type-1 receptors.
Hancock AA; Buckner SA; Lee JY; Brune M; Morse PA; Oheim K; Warner RB; Winn M; Zydowsky TM; De B
Life Sci; 1993; 53(11):929-37. PubMed ID: 8366760
[TBL] [Abstract][Full Text] [Related]
46. Quantitation of a new potent angiotensin II receptor antagonist, TCV-116, and its metabolites in human serum and urine.
Miyabayashi T; Okuda T; Motohashi M; Izawa K; Yashiki T
J Chromatogr B Biomed Appl; 1996 Feb; 677(1):123-32. PubMed ID: 8925084
[TBL] [Abstract][Full Text] [Related]
47. Tight binding of the angiotensin AT(1) receptor antagonist.
Fierensa FL; Vanderheyden PM; Roggeman C; De Backer J; Thekkumkara TJ; Vauquelin G
Biochem Pharmacol; 2001 May; 61(10):1227-35. PubMed ID: 11322926
[TBL] [Abstract][Full Text] [Related]
48. 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.
Ries UJ; Mihm G; Narr B; Hasselbach KM; Wittneben H; Entzeroth M; van Meel JC; Wienen W; Hauel NH
J Med Chem; 1993 Dec; 36(25):4040-51. PubMed ID: 8258826
[TBL] [Abstract][Full Text] [Related]
49. [Angiotensin II receptor antagonists].
Naka T
Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):956-60. PubMed ID: 10771657
[No Abstract] [Full Text] [Related]
50. Development of 3D-QSAR CoMSIA models for 5-(biphenyl-2-yl)-1H-tetrazole derivatives as angiotensin II receptor type 1 (AT1) antagonists.
Choi MJ; Kwon GH; Han NS; Yoo BW; Kim JH; Paik SH; Chi YH; Lee KT; Lee JY
Bioorg Med Chem Lett; 2013 Aug; 23(16):4540-6. PubMed ID: 23845221
[TBL] [Abstract][Full Text] [Related]
51. Nonpeptidic angiotensin II AT₁ receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles.
Zhang J; Wang JL; Yu WF; Zhou ZM; Tao WC; Wang YC; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
Eur J Med Chem; 2013 Nov; 69():44-54. PubMed ID: 24007859
[TBL] [Abstract][Full Text] [Related]
52. Discovery of novel, potent and low-toxicity angiotensin II receptor type 1 (AT1) blockers: Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazoles with a chiral center.
Han XF; He X; Wang M; Xu D; Hao LP; Liang AH; Zhang J; Zhou ZM
Eur J Med Chem; 2015 Oct; 103():473-87. PubMed ID: 26397395
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists.
Kaur N; Kaur A; Bansal Y; Shah DI; Bansal G; Singh M
Bioorg Med Chem; 2008 Dec; 16(24):10210-5. PubMed ID: 19013821
[TBL] [Abstract][Full Text] [Related]
54. [Pharmacological characteristics of ARB and potential strategy to develop novel ARB].
Kim-Mitsuyama S
Nihon Rinsho; 2009 Apr; 67(4):812-8. PubMed ID: 19348247
[TBL] [Abstract][Full Text] [Related]
55. New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties, and structure-activity relationships of 2-alkyl benzimidazole derivatives.
Thomas AP; Allott CP; Gibson KH; Major JS; Masek BB; Oldham AA; Ratcliffe AH; Roberts DA; Russell ST; Thomason DA
J Med Chem; 1992 Mar; 35(5):877-85. PubMed ID: 1548677
[TBL] [Abstract][Full Text] [Related]
56. Pharmacology of angiotensin receptors and AT1 receptor blockers.
Chung O; Unger T
Basic Res Cardiol; 1998; 93 Suppl 2():15-23. PubMed ID: 9833157
[No Abstract] [Full Text] [Related]
57. Effects of a nonpeptide angiotensin II receptor antagonist (CV-11974) on [Ca2+]i and cell motion in cultured ventricular myocytes.
Kinugawa K; Kohmoto O; Takahashi T; Serizawa T
Eur J Pharmacol; 1993 Apr; 235(2-3):313-6. PubMed ID: 8508911
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and structure-activity relationship of a new series of potent angiotensin II receptor antagonists: pyrazolo[1,5-a]pyrimidine derivatives.
Shiota T; Yamamori T; Sakai K; Kiyokawa M; Honma T; Ogawa M; Hayashi K; Ishizuka N; Matsumura K; Hara M; Fujimoto M; Kawabata T; Nakajima S
Chem Pharm Bull (Tokyo); 1999 Jul; 47(7):928-38. PubMed ID: 10434395
[TBL] [Abstract][Full Text] [Related]
59. Synthesis, characterization and antihypertensive activity of 2-phenyl substituted benzimidazoles.
Khan MT; Razi MT; Jan SU; Mukhtiar M; Gul R; IzharUllah -; Hussain A; Hashmi AM; Ahmad MT; Shahwani NA; Rabbani I
Pak J Pharm Sci; 2018 May; 31(3(Supplementary)):1067-1074. PubMed ID: 29731445
[TBL] [Abstract][Full Text] [Related]
60. Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships.
Kim KS; Qian L; Bird JE; Dickinson KE; Moreland S; Schaeffer TR; Waldron TL; Delaney CL; Weller HN; Miller AV
J Med Chem; 1993 Aug; 36(16):2335-42. PubMed ID: 8360878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
